Physician profile
Keith R Layne
NPI 1407843212
$656.03
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $94.29 · 2022: $62.67 · 2023: $116 · 2024: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $191.70 | 2019-2024 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $122.73 | 2023-2024 | |
| Ironshore Pharmaceuticals INC. | $81.78 | 2019-2020 | |
| Novo Nordisk INC | $47.90 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $40.26 | 2019 | |
| Allergan, INC. | $34.81 | 2019 | |
| Supernus Pharmaceuticals, INC. | $31.24 | 2022-2023 | Qelbree |
| Pfizer INC. | $25.72 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $21.98 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.08 | 2020 | |
| Exact Sciences Corporation | $16.90 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $11.90 | 2019 | |
| Medtronic Minimed, INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Layne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.